| | Class 2 Device Recall Artegraft |  |
| Date Initiated by Firm | September 25, 2025 |
| Date Posted | October 23, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0289-2026 |
| Recall Event ID |
97700 |
| Product Classification |
Tissue graft of 6mm and greater - Product Code LXA
|
| Product | Artegraft Collagen Vascular Graft;
REF: AG1015; |
| Code Information |
REF: AG1015;
UDI-DI: 00316837000343;
Lot/Serial Number: 23MM581-016; |
Recalling Firm/ Manufacturer |
LeMaitre Vascular, Inc. 206 N Center Dr North Brunswick NJ 08902-4246
|
| For Additional Information Contact | Timothy Rodenberger 781-362-5449 |
Manufacturer Reason for Recall | The device was incorrectly packed in the wrong size labeled outer packaging. |
FDA Determined Cause 2 | Packaging change control |
| Action | On September 25, 2025, an "URGENT: MEDICAL DEVICE RECALL" letter was sent to the customer.
Actions to be taken:
Check your inventory against the list of lots in this letter. Immediately quarantine any
recalled devices. Complete and return the form provided even if you have no devices in inventory. If the product has been implanted, graft explantation/patient intervention is NOT required. Scan the reply form and send it to recalls@lemaitre.com. When a recalled device has been returned to LeMaitre Vascular, a replacement device will be provided.
If you have transferred devices to another facility, please forward a copy of this recall
letter to them.
If you have any questions, contact Sr. Director, Quality Affairs, via email: mnelson@lemaitre.com or at 732-422-8333 Monday through Friday, 8:00AM to 4:30 PM, Eastern Time. |
| Quantity in Commerce | 1 unit |
| Distribution | US distribution to the state of: AR |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|